ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106. A total of 100 filers reported holding ADAMAS PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 0.13 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2020 | $32,000 | -96.8% | 11,020 | -95.9% | 0.00% | – |
Q4 2019 | $1,012,000 | -80.6% | 266,837 | -73.8% | 0.00% | -100.0% |
Q3 2019 | $5,212,000 | +8.6% | 1,018,995 | +31.6% | 0.00% | 0.0% |
Q2 2019 | $4,800,000 | +348.2% | 774,295 | +414.2% | 0.00% | – |
Q1 2019 | $1,071,000 | -16.8% | 150,590 | -0.2% | 0.00% | -100.0% |
Q4 2018 | $1,288,000 | -30.0% | 150,843 | +177.8% | 0.00% | 0.0% |
Q4 2017 | $1,841,000 | +0.1% | 54,295 | -16.4% | 0.00% | 0.0% |
Q4 2015 | $1,840,000 | – | 64,978 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 1,423,578 | $8,826,000 | 6.08% |
Healthcare Value Capital, LLC | 200,000 | $1,240,000 | 2.33% |
ARMISTICE CAPITAL, LLC | 2,700,000 | $16,740,000 | 1.06% |
DELTEC ASSET MANAGEMENT LLC | 550,836 | $3,415,000 | 0.75% |
Broadfin Capital, LLC | 441,088 | $2,735,000 | 0.60% |
Kerrisdale Advisers, LLC | 229,347 | $1,422,000 | 0.51% |
Worth Venture Partners, LLC | 87,908 | $545,000 | 0.30% |
Mosaic Family Wealth, LLC | 91,314 | $566,000 | 0.24% |
EMERALD ADVISERS, LLC | 700,176 | $4,341,000 | 0.17% |
EMERALD MUTUAL FUND ADVISERS TRUST | 616,664 | $3,823,000 | 0.15% |